FDA Approves Onswik: A Once-Weekly Insulin For Adults With Type 2 Diabetes
If you live with type 2 diabetes (T2D) and find the frequency of multiple daily injections (MDI) dauntinghere’s a bit of good news: Eli Lilly announced the Food and Drug…
If you live with type 2 diabetes (T2D) and find the frequency of multiple daily injections (MDI) dauntinghere’s a bit of good news: Eli Lilly announced the Food and Drug…
The US Food and Drug Administration (FDA) has approved Eli Lilly and Company’s Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with type 2 diabetes (T2D). This…
September 24, 2026 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
FDA approved of Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin indicated along with diet and exercise to control high blood sugar in adults with type 2 diabetes. With FDA’s…